drugset / Trial / NCT02090998

Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transformed Migraines

NCT02090998

Phase 4 Terminated 10 enrolled Rutgers, The State University of New Jersey
RandomizedParallel-groupOpen-labelPrevention

Summary

This study will compare a local anesthetic technique that has been used to treat subjects suffering from transformed migraines (chronic migraines) versus medical management with traditional antidepressant Amitriptyline / Elavil. Subjects will be randomized into one of two treatment groups to compare the safety and efficacy of the therapies. Subjects will recieve either sphenopalatine ganglion nerve block with 5% lidocaine gel into the nasopharynx or medical management with traditional antidepressants, Elavil, to produce a reduction in the frequency and severity of the headache. We propose that there will be a difference in the outcomes when comparing the two methods of treating transformed migraines and that one research arm will result in more patient satisfaction and greater efficacy in the treatment of subjects

Timeline

Start
2014-05
Primary completion
2020-03-16
Completion
2020-03-16

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amitriptyline Small molecule 20 mg Oral

Indications